Gender differences in comorbidity of conduct disorder among adolescents in Northern Finland by Ilomaki, Essi et al.
Gender differences in comorbidity of
conduct disorder among adolescents in
Northern Finland
Essi Iloma¨ki1*, Helina¨ Hakko2, Risto Iloma¨ki1, Pirkko Ra¨sa¨nen1,2
and STUDY-70 workgroup
1Department of Psychiatry, University of Oulu, Oulu, Finland; 2Department of Psychiatry, Oulu University
Hospital, Oulu, Finland
Objectives: Conduct disorder (CD) refers to a pattern of severe antisocial and aggressive behaviour
manifested in childhood or adolescence, with heavy costs to society. Though CD is a common psychiatric
diagnosis among adolescents of both genders, gender differences in comorbidity of CD have been little
studied. In this study we examined gender differences among adolescents with CD in causes for
hospitalization, comorbid psychiatric diagnoses and somatic conditions.
Study design: The original study sample consisted of 508 inpatient adolescents in Northern Finland
(age 1217); 155 of them (65 girls, 92 boys) fulfilled the DSM-IV criteria for CD.
Methods: Diagnosis of CD and psychiatric comorbidities were obtained from the K-SADS-PL and somatic
conditions from the EuropAsi.
Results: As compared to boys with CD, suicidality (including suicidal ideation and behaviour) was
significantly more commonly the cause of hospitalization among girls with CD (43% vs. 24%, p0.013).
Among somatic conditions, there was a significant predominance in self-reported allergies among girls (60%
vs. 25%, pB0.001). Girls had more often diagnosed comorbid post-traumatic stress disorder (13% vs. 3%,
p0.025) and marginally significantly more major depressive disorder (36% vs. 23%, p0.086).
Conclusions: Girls with CD seem to have an increased tendency to develop both comorbid psychiatric and
somatic conditions as well as suicidality. New clinical aspects in treatment of CD and comorbid disorders
among girls are discussed.
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A
s described in DSM-IV, conduct disorder (CD)
involves ‘‘a repetitive and persistent pattern of
behaviour in which the basic rights of others or
major age-appropriate social norms or rules are violated’’
(1). Estimated lifetime prevalence of CD in the US is
6.89.5% (2,3). In Finland comprehensive epidemiologi-
cal research on the prevalence of CD among adolescents
is lacking; however Almqvist and colleagues found that
among 8- to 9-year-old Finnish children the combined
prevalence of CD and oppositional defiant disorder using
DSM-III-criteria was 4.7% (4). In Arctic countries the
prevalence of CD has not been researched systematically,
and special features of CD in high latitudes are not
reported. Especially among indigenous people in the
Arctic, the research of adolescents’ mental health is
limited mainly to substance abuse and suicidality (5).
However, it has been reported that in an American Indian
reservation population of Alaska the prevalence of CD is
higher than generally in US/Canada (6). Also behaviour-
al disorders are reported twice as common in Siberia as in
Great Britain (7). The prevalence of CD has been
increasing globally, especially among girls (8,9), and it
consumes much of the resources of mental health,
juvenile justice and the special education system. The
number of physical assaults committed by Finnish girls
and the percentage of female assaulters have increased
since the mid-90s (10). Both clinicians working with
adolescents, school psychologists, educators, paediatri-
cians and criminologists meet CD regularly. As a
diagnosis easily categorized among one of the most
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treatment-resistant, the results of leaving these patients
untreated can lead to even greater costs to society  not
to mention the adolescents themselves (11).
Comorbidity in psychiatric disorders among adoles-
cents is more a rule than an exception. There is evidence
that adolescents with comorbid internalizing or externa-
lizing disorders are more likely to have continuing
problems than adolescents with only a single disorder
(12), and comorbid individuals are more than twice as
likely to be among psychiatric services than individuals
with only a single diagnosis (13).
Adolescents with CD have also a strong tendency for
comorbid psychiatric conditions (14), which can be
experienced demanding in treatment. However, comorbid
conditions might provide a way to treat patients with CD
otherwise hard to treat and perhaps protesting treatment.
General guidelines for efficient treatment for CD are
lacking, as is solid evidence for drug treatment despite
continuous research in that field. Tcheremissine and
Lieving (11) suggest in their review that several drug
groups can be effective therapeutic options for indivi-
duals with CD and comorbid psychiatric conditions.
Multisystemic therapy is perhaps the most widely used
psychosocial treatment for CD and behavioural problems
(15), although its results are also somewhat weak (16).
Gender differences in treatment of CD have been poorly
examined (9).
There has been extensive research on comorbid
psychiatric diagnoses of CD, but it has mostly been
based on data limited in males, not been gender-specific,
or the proportion of girls in the analyses has been small
(14). Gender differences are, probably due to previous,
scarcely studied. Attention deficit hyperactivity disorder
(ADHD) is found to influence the development of CD,
and comorbidity exists among both genders (17). The
prevalence of depression among adolescents with CD
varies from 8 to 46% (18,14), while in some studies the
connection was not found (19). Also anxiety disorders are
common comorbid conditions for CD. The prevalence of
anxiety disorders varies between 13 and 69% (14,20).
Substance use disorders as comorbid disorders for CD
are common (21)  in clinical populations of adolescent
substance users the comorbidity of substance use dis-
orders and behavioural disorders is even as high as 95%,
and this comorbidity appears to be pronounced among
girls (22). It is said about gender differences in comorbid
diagnoses of CD that females have more internalizing
comorbid conditions, such as depression (14,23) and
different anxiety disorders (23). Gender-neutral findings
have also observed (20).
Even though it is known that somatic conditions and
general health problems are connected with antisocial
personality disorder in adulthood (24), there are only few
studies on the connection between somatic disorders and
CD among adolescents. The focuses of these studies by
Hanssen-Bauer et al. (25) and Dunn et al. (26) are mainly
on neurological conditions. Also, in earlier literature 
while CD has not been studied  depressive and anxiety
disorders have been associated with atopic disorders
among both adolescents and adults (27,28).
The aim of this study was to investigate comorbidity of
CD in a clinical data set of hospitalized adolescents in
Northern Finland. It was anticipated that in this data set
with the most severe adolescent psychiatric cases comor-
bidity would be found, and that there would be enough
data of girls (and boys) with CD to examine gender dif-
ferences. We focused out attention on gender differences
in (a) psychiatric comorbidity, (b) somatic comorbidity,
and (c) causes for admission to psychiatric hospital.
Material and methods
Participants
The STUDY-70 project was initiated to examine the
association of various psychosocial risk factors with the
outcomes of severe psychiatric and substance disorders
among hospital-treated adolescents aged 1217 years in
Northern Finland. The basic study sample consisted of
508 adolescents (208 boys, 300 girls) admitted to Unit 70
at Oulu University Hospital, the Department of Psychia-
try, between April 2001 and March 2006. The catchment
area of Unit 70 covers the districts of Oulu and Lapland:
all adolescents from this area in need of acute psychiatric
hospitalization in a closed ward are initially treated in
Unit 70. The study protocol was approved by the Ethics
Committee of the University Hospital of Oulu (Finland).
Instruments
The subjects were interviewed by a treating physician or a
trained medical student under the surveillance of the
physician using the Finnish version of Schedule for
Affective Disorder and Schizophrenia for School-Age
Children Present and Lifetime (K-SADS-PL) to obtain
DSM-IV diagnoses and variables of age, smoking status
and family structure. The K-SADS-PL is a semi-struc-
tured diagnostic interview designed to assess current and
past episodes of psychopathology in children and ado-
lescents according to DSM-III-R and DSM-IV criteria
and it is known to be a reliable tool for defining DSM-IV-
diagnoses (29). Finnish version of K-SADS-PL has been
translated into Finnish and then reversely translated back
to English to certify the accuracy of translation.
K-SADS-PL has been used in numerous studies on
adolescents in Finland (30). If data were missing or
remained unreliable after interviewing the adolescent, the
interview was complemented by interviewing the adoles-
cent’s parents. Data were recorded on the basis of both
the patients’ information and physician’s evaluation of
the diagnostic interview (31). An objective face-to-face
structured interview, the European Addiction Severity
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Index (EuropASI) (32) performed by the staff in the unit,
was used to assess dwelling place, living in rural area and
repeating grades, as well as to obtain the prevalence of
somatic conditions.
Definition of CD
Current DSM-IV-based psychiatric diagnosis for CD
(diagnostic code 312.8) according to the K-SADS-PL
interview was used in this study. Of the total study
population, 155 (31.5%) suffered from CD, and this
formed the study sample of the present study. Of these
155 adolescents, 63 (40.6%) were girls and 92 (59.4%)
boys.
Definitions of causes for psychiatric hospital
admission
Causes for hospitalization were gathered from the semi-
structured admission form included in patients’ hospital
case notes, which was completed together by the treating
physician, nurse and the patient and/or patient’s parents
at the beginning and in the end of treatment episode at
unit 70. This information was afterwards categorized into
8 components: depressive mood, suicidality (including
both suicidal ideation and behaviour), psychotic symp-
toms, anxiety symptoms, substance use, behavioural
problems, aggressive behaviour and sleeping disorders.
Definitions of somatic conditions
Information on somatic conditions was extracted from
the EuropAsi. Self-reported allergy was defined as
positive, if the patient or his/her parents reported the
patient to have any allergies (yes/no). Regular medication
for somatic condition was defined as present (yes/no),
when the adolescent had daily and continual doctor-
prescribed medication for a somatic condition. Chronic,
life-disturbing disease was defined as being present (yes/
no) if the adolescent had a chronic, diagnosed somatic
condition that subjectively disturbed everyday life.
Comorbid psychiatric diagnoses
Current comorbid psychiatric diagnoses were obtained
from the K-SADS-PL interview following DSM-IV
criteria (29,1). We examined DSM-IV-diagnosed MDD,
panic disorder, simple phobia, social phobia, agorapho-
bia, generalized anxiety disorder, post-traumatic stress
disorder (PTSD), attention deficient hyperactivity dis-
order (ADHD), alcohol abuse, alcohol dependence, drug
abuse and drug dependence as comorbid diagnoses for
CD. We also examined separation anxiety disorder, but
the number of cases was too small for reasonable
statistical analyzes.
Traumas of adolescents with PTSD and CD
The information concerning etiological traumas behind
the symptoms of PTSD were gathered from the K-SADS-
PL. In order to maintain anonymity of the patients,
the distinctive traumas of adolescents were categorized
into 8 groups (sexual abuse, physical abuse, parental
physical abuse, interparental violence, witness of violence,
death of a relative, death of a friend and car-accident).
Statistical methods
Statistical significance of group differences in categorical
variables was assessed with Pearson’s Chi-square test or
Fisher’s Exact test, and in continuous variables with
Student’s t-test or Mann-Whitney U-test. All tests were
2-sided and the limit for statistical significance was set at




Table I shows the background information for girls and
boys with CD separately. None of the background
characteristics differed statistically significantly between
genders.
Causes for hospitalization
Table II shows the results of the causes for hospitalization
of adolescents with CD. The most common cause for girls
with CD was suicidality, and within that variable there
was also a statistically significant gender difference (girls
43% vs. boys 24%, p0.013). Among boys with CD the
most common reason for hospitalization was aggressive
symptoms, but the gender difference remained non-
significant. An equal proportion of boys (40, 43.5%)
and girls (28, 44.4%) were in involuntary treatment
(p0.905). Two or more causes for admission were
observed in 73 (47.1%) adolescents; 32 (50.8%) in females
and 41 (44.6%) in males (p0.445).
Further analyzes revealed that among adolescents with
CD, the prevalence of suicidality as a cause for admission
was 51% if adolescent had comorbid MDD as compared
to 24% among those who weren’t depressed (df1, chi-
square 10 520, p-valueB0.001). However, it was also
noteworthy that only 45% of all suicidal adolescents had
diagnosed MDD. The mean number of comorbidities
among adolescents who were hospitalized for suicidality
was 1.82 (SD1.44) and among those adolescents
whose cause of hospitalization was other than suicidality
1.51 (SD1.38, p-value0.206).
Comorbid somatic conditions
Comorbid somatic conditions of adolescents with CD are
presented in Table III. A statistically significant female
predominance was observed in allergies (60% vs. 25%,
pB0.001).
Comorbid psychiatric disorders
Comorbidity of psychiatric disorders was common
among both genders (Table IV). 79% of adolescents
with CD presented at least 1 other psychiatric (including
Gender differences in comorbidity of conduct disorder
Citation: Int J Circumpolar Health 2012, 71: 17393 - DOI: 10.3402/ijch.v71i0.17393 3
(page number not for citation purpose)
substance use disorders) condition. The mean number of
comorbid diagnoses was 1.5 (SD1.4) for boys and 1.8
(1.4) for girls, no gender difference was found (T-test
p-value0.136). Table IV shows that girls with CD had
statistically significantly more PTSD (12.7% vs. 3.3%,
p0.025), and a trend-like excess of MDD when
compared to boys (35.5% vs. 22.8%, p0.086). The
traumatic etiology of PTSD is displayed in the Table V.
In majority of cases, adolescents experienced PTSD-
symptoms from multiple traumas.
MDD and allergy among adolescents with CD
Additional analyses were performed to investigate co-
morbidity between MDD and allergy among adolescents
with CD, since an earlier study has shown an association
between these 2 health conditions (28). In our data
among girls with CD, MDD was statistically significantly
more common among allergic girls compared to those
without allergies (45.9% vs. 20.0%, x24.39, p0.036),
while among boys with CD no association was observed
(21.7% vs. 23.5%, x20.03, p0.860).
Discussion
In this study, both adolescent girls and boys with CD had
a very high, up to 80%, rate of comorbidity of any DSM-
IV-diagnosed psychiatric disorder. This observation was
made in a sample of under-aged patients (i.e. adolescents
aged 1217 years). We found that girls suffering from CD
had more PTSD than boys, and we also observed a trend
of girls having more MDD as a psychiatric comorbid
diagnosis than boys. Girls with CD had more suicidality
as a cause for admission to psychiatric hospital when
compared to boys. Another interesting finding was the
very high self-reported rate of allergies among girls with
CD when compared to boys (60 vs. 25%).
In this study, suicidality as a cause for hospitalization
was more common among girls, which is in line with
earlier literature (33). As in earlier studies (14), also in
this study there was a trend of girls having more MDD,
even if the result did not reach statistical significance.
From a clinical point of view, as girls with CD seem to be
more vulnerable comorbid depression, it is possible that
this could be a key for treating these adolescent girls more
Table I. Background information of girls and boys suffering from conduct disorder (CD)
Total (n155) Girls (n63) Boys (n92) Gender difference
n (%) n (%) n (%) p-value*
Mean age (SD) at admission, in years 15.5 (1.4) 15.6 (1.3) 15.5 (1.5) 0.585
Living in urban area with population 100,000 34 (21.9) 16 (25.4) 18 (19.6) 0.389
Repeated grades in comprehensive school 31 (20.0) 9 (14.3) 22 (23.9) 0.141
Living in primary family (at least 1 biological parent) 74 (47.7) 32 (50.8) 42 (45.7) 0.529
Daily smoking (at least 1 cig. per day) 133 (85.8) 52 (82.5) 81 (88.0) 0.335
Note: Figures are numbers and percentages if not otherwise specified. Variables are from the K-SADS-PL interview, expect dwelling place
from EuropAsi.
*Pearson x2-test or Fisher’s Exact test, 2-tailed significance.
Table II. Causes for admission to psychiatric hospital among adolescents suffering from conduct disorder (CD)
Total (n155) Girls (n63) Boys (n92) Gender difference
n (%) n (%) n (%) p-value*
Depressive mood 36 (23.2) 17 (27.0) 19 (20.7) 0.359
Suicidality 49 (31.6) 27 (42.9) 22 (23.9) 0.013
Psychotic symptoms 13 (8.4) 4 (6.3) 9 (9.8) 0.449
Anxiety symptoms 20 (12.9) 7 (11.1) 13 (14.1) 0.582
Substance use 22 (14.2) 9 (14.3) 13 (14.1) 0.978
Behavioral problems 34 (21.9) 16 (25.4) 18 (19.6) 0.389
Aggressive symptoms 45 (29.0) 14 (22.2) 31 (33.7) 0.122
Sleep disorders 3 (1.9) 2 (3.2) 1 (1.1) 0.354
Note: Variables are extracted from the semi-structured admission form used in the Department of Psychiatry at Oulu University Hospital.
* Pearson x2-test or Fisher’s Exact test, 2-tailed significance.
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efficiently, for example with SSRI medication. Also,
clinicians know how difficult it is to treat a adolescent
with CD but often without willing to get treated  who is
more and more often a girl  treatment of comorbid
internalizing psychiatric disorder could lead to more co-
operative treatment. The risk for suicidal behaviour must
always be taken into consideration when meeting a girl
with CD, especially when suspecting comorbid MDD.
However, the prevalence of suicidality in our study was
even greater than that of comorbid depression. Earlier
studies have shown that CD is an independent risk factor
for suicidality (34), and that multiple co-morbid psychia-
tric conditions have an increased risk of suicidal beha-
viour (35), which could explain the high rate of suicidality
among adolescent girls with CD, even in the absence of
clinical depression. As stated in the article by Apter and
colleagues in 1995 (34): ‘‘It seems that there are hypothe-
tically at least two types of suicidal behaviors during
adolescence: a wish to die (depression) and a wish not to
be here for a time (impulse control)’’.
PTSD is known to be a diagnosis that commonly co-
occurs with other psychiatric diagnoses (36). The finding
of girls with CD having more PTSD than boys is
somewhat alarming; girls with CD might seek or get
into situations where traumatic experiences are more
likely to happen. Further, it is even more alarming that
the etiology behind the PTSD is extensive and highly
malignant as compared to normal adolescent life in
general population. On the other hand, we cannot
conclude causality from our cross-sectional data, and
it is also possible that CD is secondary for PTSD.
Further studies of this matter are needed to explain the
causality.
The prevalence of allergic diseases (asthma, allergic
rhinitis, atopic dermatitis) in general population samples
from different countries has been found to be from 14 to
Table III. Comorbid somatic conditions of adolescents suffering from conduct disorder (CD)
Total (n155) Girls (n63) Boys (n92) Gender difference
n (%) n (%) n (%) p-value
Allergy 60 (39.2) 37 (59.7) 23 (25.3) B0.001
Regular medication for somatic condition 11 (7.2) 4 (6.3) 7 (7.8) 0.736
Chronic, life-disturbing disease 20 (13.0) 11 (17.5) 9 (9.9) 0.169
HIV-infection 1 (0.6) 0 (0.0) 1 (1.1) 1.000
Hepatitis B or C 4 (2.6%) 3 (4.8) 1 (1.1) 0.156
Note: All variables are obtained from the EuropAsi questionnaire.
* Pearson x2-test or Fisher’s Exact test, 2-tailed significance.
Table IV. Comorbid psychiatric disorders of adolescents with conduct disorder (CD)
Total (n155) Girls (n63) Boys (n92) Gender difference
n (%) n (%) n (%) p-value*
Major depressive disorder 43 (27.9) 22 (35.5) 21 (22.8) 0.086
Panic disorder 5 (3.2) 3 (4.8) 2 (2.2) 0.397
Simple phobia 4 (2.6) 2 (3.2) 2 (2.2) 1.000
Social phobia 10 (6.5) 4 (6.3) 6 (6.5) 1.000
Agoraphobia 8 (5.2) 5 (7.9) 3 (3.3) 0.271
Generalized anxiety disorder 3 (1.9) 1 (1.6) 2 (2.2) 1.000
Post-traumatic stress disorder 11 (7.1) 8 (12.7) 3 (3.3) 0.025
Attention deficit hyperactivity disorder 16 (10.3) 6 (9.5) 10 (10.9) 0.787
Alcohol misuse 51 (32.9) 21 (33.3) 30 (32.6) 0.925
Alcohol dependence 40 (25.8) 18 (28.6) 22 (23.9) 0.515
Drug misuse 22 (14.2) 8 (12.7) 14 (15.2) 0.659
Drug dependence 33 (21.3) 13 (20.6) 20 (21.7) 0.869
Any comorbid psychiatric disorder 119 (76.8) 50 (79.4) 69 (75.0) 0.527
Note: All variables are obtained from the K-SADS-PL interview. Table includes only those diagnostic groups in which the number of cases
was sufficient for statistical analyses.
* Pearson x2-test or Fisher’s Exact test, 2-tailed significance.
Gender differences in comorbidity of conduct disorder
Citation: Int J Circumpolar Health 2012, 71: 17393 - DOI: 10.3402/ijch.v71i0.17393 5
(page number not for citation purpose)
32% (37,38), being higher and increasing in Western
countries (39). A recent study on Finnish adolescents
aged 1516 years reported a 25% prevalence of allergic
diseases (40). Gender differences in prevalence of allergies
are contradictory and reported to be minor. In Finnish
adolescent data boys are reported to have more asthma
than girls, while no significant gender difference was
found in the prevalence of allergic rhinitis (41). Our
finding of girls with CD having more self-reported
allergies than boys (60 vs. 25%) is novel and extremely
interesting. This finding can be partly  but not entirely 
explained by predominance of comorbid MDD among
girls, since it has been documented that there is a
connection between allergies and depression, especially
among females (28). Even in our study among girls
with CD, allergies were more common among girls with
CD and depression than among those with only CD.
However, the fact that in this study half of the girls with
CD but no MDD had self-reported allergy is a more than
good reason for further research on the connection
between CD and atopic disorders especially among
females. Whether the gender difference actually exists,
or whether boys neglect to report their allergic disorders
needs further research of this matter by using validated
and objective measures of atopic disorders.
The main limitation of the present study is that the
sample consisted of the most severe, hospitalized mani-
festations of the psychiatric disorders studied, presum-
ably with increased rates of co-morbidity when compared
to general population. This limits the generalization of
our findings to all adolescents with less severe problems.
In this data set the prevalence of allergies was based on
self-reports, which might differ from true prevalence, and
are possibly underestimates.
The strengths of this study were that all the patients
were interviewed by a treating physician or a trained
medical student under the surveillance of the physician,
and that the data were gathered using established semi-
structured interviews (29,32). The study sample con-
sisted of all hospitalized psychiatric adolescent patients
in a geographically large area in northern Finland, and
thus it represents the most serious cases in the general
adolescent population. Further, the strengths included
a reasonable sample size of adolescents with CD, espe-
cially females, to examine gender differences, which is
why this study also brings an important addition to earlier
literature.
In sum, CD is known to be a difficult and complicated
disorder to treat. Our study shows, that according to
present diagnostic criteria, adolescents with CD have a
tendency to develop comorbid psychiatric conditions that
are somewhat gender specific. While treatment of CD
per-se has been found challenging, the treatment of these
comorbid conditions might have a big and important role
in treating adolescents with CD.
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